Skip to main content
ISRG logo

Intuitive Surgical Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Instruments & Supplies

Intuitive, headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most. About da Vinci Surgical Systems There are several models of the da Vinci Surgical System. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body. About the Ion Endoluminal System The Ion Endoluminal System (Model IF1000) assists the user in navigating a catheter and endoscopic tools in the pulmonary tract using endoscopic visualization of the tracheobronchial tree for diagnostic and therapeutic procedures. The Ion Endoluminal System enables fiducial marker placement. It does not make a diagnosis and is not for pediatric use. Information provided by the Ion Endoluminal System or its components should be considered guidance only and not replace clinical decisions made by a trained physician.

Did you know?

A large-cap company with a $159.7B market cap.

Current Price

$450.62

-0.95%

GoodMoat Value

$225.00

50.1% overvalued
Profile
Valuation (TTM)
Market Cap$159.74B
P/E55.93
EV$163.53B
P/B8.96
Shares Out354.50M
P/Sales15.87
Revenue$10.06B
EV/EBITDA38.76

Intuitive Surgical Inc (ISRG) Financial Statements

GoodMoat Analysis

Based on data as of March 26, 2026

Intuitive Surgical exhibits strong operational growth and profitability, with revenue up 18.8% YoY and robust operating margins of 29.3%. However, its free cash flow generation is currently weak relative to its market cap, and its valuation multiples appear demanding for a value investor.

Read full analysis
Intuitive Surgical's financial quality is mixed under the GoodMoat framework. On the positive side, the company demonstrates strong revenue growth of 18.8% YoY, which is a favourable indicator. Its profitability metrics are excellent, with a 29.3% operating margin and a 28.4% profit margin, indicating significant pricing power and operational efficiency. The balance sheet appears healthy with negligible debt, a favourable sign for financial resilience. However, the free cash flow picture is a point of concern. The reported FCF yield of 1.5% is low, translating to a high Price-to-Free Cash Flow multiple. This falls short of the framework's quality threshold for a strong FCF margin (>10-15%) and high conversion. While the Return on Equity of 16.0% is respectable, it does not clearly exceed the high bar of 15-20% for Return on Invested Capital (ROIC) set in the framework. The primary challenge for a value investor is the valuation context; a P/E of 58.3 is extremely high, suggesting the market has priced in near-perfect execution of future growth, leaving little margin of safety. The growth trajectory is strong, but the financial quality is tempered by weak current cash generation relative to its size and premium pricing. Analysis based on data as of 2024-05-15.

ISRG Financial Data

EBITDA$3.97B
Revenue (TTM)$10.06B
Gross Profit (TTM)$6.64B
Gross Margin
Operating Margin29.27%
ROE16.02%
ROA13.96%
Debt/Equity
Current Ratio4.87
FCF$2.49B
FCF Yield1.56%
Piotroski F-Score
Rev/Share (TTM)$28.39
50-Day MA$482.63
200-Day MA$504.84
Shares Outstanding0.35B

ISRG Computed Insights

FCF$2.49B
FCF Growth Rate13.38%
EPS Growth (CAGR)13.38%
WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

ISRG Financial Statements & Data

Intuitive Surgical Inc (ISRG) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Intuitive Surgical Inc's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $10.06B. Gross profit (TTM) is $6.64B. EBITDA is $3.97B. Earnings per share (EPS) is $7.87. The P/E ratio is 55.93. Market capitalization is $159.74B.

Free cash flow (FCF) is $2.49B. FCF growth rate is 13.38%. EPS growth CAGR is 13.38%. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Intuitive Surgical Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.